Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) VP Nathalie Adda sold 50,559 shares of the firm’s stock in a transaction that occurred on Friday, April 1st. The stock was sold at an average price of $71.23, for a total value of $3,601,317.57. The sale was disclosed in a filing with the SEC, which is available […]